13. 多発性硬化症/視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details


臨床試験数 : 3,342 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 266 - 標的パスウェイ数 : 240

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01777412
(ClinicalTrials.gov)
June 201321/1/2013Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO ExacerbationsAn Open-label Phase 1b Study of Avastin® (Bevacizumab) for the Treatment of Acute Optic Neuritis and/or Transverse Myelitis in Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD).Neuromyelitis Optica;Neuromyelitis Optica Spectrum DisorderDrug: BevacizumabJohns Hopkins UniversityGenentech, Inc.;Guthy Jackson Charitable FoundationCompleted18 Years70 YearsAll10Phase 1United States